Male (n = 62) | Female (n = 204) | ||
---|---|---|---|
Age at initial evaluation (years) | 6.69 +/− 2.37 | 6.33 +/− 1.83 | NS |
Age at initial symptoms (years) | 5.08 +/− 2.41 | 4.58 +/− 1.89 | NS |
Weight z-score | 1.40 +/− 1.39 | 1.21 +/− 1.32 | NS |
BMI z-score | 1.38 +/− 1.27 | 1.21 +/− 1.20 | NS |
Systolic BP | 103 +/− 7.4 | 103 +/− 8.03 | NS |
Diastolic BP | 65 +/− 6.7 | 64.5 +/− 6.70 | NS |
Hypertension | 12.9% | 12.3% | NS |
Tanner stage (pubic hair) | 2.18 +/− 0.61 | 2.31 +/− 0.57 | NS |
Testosterone (ng/dL) | 7.64 +/− 5.56 | 7.68 +/− 10.0 | NS |
17-OH progesterone (ng/dL) | 27.91 +/− 36.34 | 28.65 +/− 22.87 | NS |
DHEA-sulfate (ug/dL) | 109.8 +/− 63.4 | 72.42 +/− 52.76 | < 0.001* |
Androstenedione (ng/dL) | 20.29 +/− 7.27 | 18.89 +/− 8.59 | NS |